Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Mandel

Showing results (91-100 of 221) with videos related to

Pageof 23
Sort By:
Clinical Genitourinary Cancer|October 26, 2019
Impact of Adherence to Multidisciplinary Recommendations for Adjuvant Treatment in Radical Prostatectomy Patients With High Risk of RecurrenceSophie Knipper, Maryam Sadat-Khonsari, Katharina Boehm, et al.
European Urology Oncology|September 21, 2024
Risk of Biochemical Recurrence and Metastasis in Prostate Cancer Patients Treated with Radical Prostatectomy After a 10-year Disease-free IntervalBenedikt Hoeh, Felix Preisser, Fabio Zattoni, et al.
European Urology Focus|July 30, 2017
Incidence, Risk Factors, Management, and Complications of Rectal Injuries During Radical ProstatectomyPhilipp Mandel, Anna Linnemannstöns, Felix Chun, et al.
Frontiers in Surgery|November 26, 2020
The Effect of Adverse Patient Characteristics on Perioperative Outcomes in Open and Robot-Assisted Radical ProstatectomyMike Wenzel, Felix Preisser, Lena H Theissen, et al.
JCO Precision Oncology|December 6, 2024
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With <i>BRCA</i> Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand TherapyMike Wenzel, Florestan Koll, Benedikt Hoeh, et al.
Urologic Oncology|January 24, 2025
Association between frailty and specific comorbidities on oncological outcomes in metastatic hormone-sensitive and castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
Frontiers in Surgery|November 12, 2019
Very Early Continence After Radical Prostatectomy and Its Influencing FactorsLena Theissen, Felix Preisser, Mike Wenzel, et al.
European Urology Focus|February 21, 2023
Prediction of Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging Lesions: A High-volume International Multicenter StudyAugust Sigle, Angelika Borkowetz, Jost von Hardenberg, et al.
Frontiers in Surgery|December 27, 2021
Influence of Biopsy Gleason Score on the Risk of Lymph Node Invasion in Patients With Intermediate-Risk Prostate Cancer Undergoing Radical ProstatectomyMike Wenzel, Felix Preisser, Benedikt Hoeh, et al.
BMC Cancer|March 2, 2026
Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohortMike Wenzel, Maximilian Filzmayer, Carolin Siech, et al.
Pageof 23

Showing results (91-100 of 221) with videos related to

Sort By:
Pageof 23
Clinical Genitourinary Cancer|October 26, 2019
Impact of Adherence to Multidisciplinary Recommendations for Adjuvant Treatment in Radical Prostatectomy Patients With High Risk of RecurrenceSophie Knipper, Maryam Sadat-Khonsari, Katharina Boehm, et al.
European Urology Oncology|September 21, 2024
Risk of Biochemical Recurrence and Metastasis in Prostate Cancer Patients Treated with Radical Prostatectomy After a 10-year Disease-free IntervalBenedikt Hoeh, Felix Preisser, Fabio Zattoni, et al.
European Urology Focus|July 30, 2017
Incidence, Risk Factors, Management, and Complications of Rectal Injuries During Radical ProstatectomyPhilipp Mandel, Anna Linnemannstöns, Felix Chun, et al.
Frontiers in Surgery|November 26, 2020
The Effect of Adverse Patient Characteristics on Perioperative Outcomes in Open and Robot-Assisted Radical ProstatectomyMike Wenzel, Felix Preisser, Lena H Theissen, et al.
JCO Precision Oncology|December 6, 2024
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With <i>BRCA</i> Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand TherapyMike Wenzel, Florestan Koll, Benedikt Hoeh, et al.
Urologic Oncology|January 24, 2025
Association between frailty and specific comorbidities on oncological outcomes in metastatic hormone-sensitive and castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
Frontiers in Surgery|November 12, 2019
Very Early Continence After Radical Prostatectomy and Its Influencing FactorsLena Theissen, Felix Preisser, Mike Wenzel, et al.
European Urology Focus|February 21, 2023
Prediction of Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging Lesions: A High-volume International Multicenter StudyAugust Sigle, Angelika Borkowetz, Jost von Hardenberg, et al.
Frontiers in Surgery|December 27, 2021
Influence of Biopsy Gleason Score on the Risk of Lymph Node Invasion in Patients With Intermediate-Risk Prostate Cancer Undergoing Radical ProstatectomyMike Wenzel, Felix Preisser, Benedikt Hoeh, et al.
BMC Cancer|March 2, 2026
Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohortMike Wenzel, Maximilian Filzmayer, Carolin Siech, et al.
Pageof 23